한글목차

세계의 조영제 강화 초음파 시장은 2024년에 22억 7,000만 달러로 평가되며, 2030년까지 CAGR 4.65%로 성장하며, 29억 8,000만 달러에 달할 것으로 예측됩니다. 조영제 강화 초음파(CEUS)는 정맥으로 투여되는 가스 충전 마이크로 버블을 이용하여 표준 의료용 초음파 검사 중 혈류 및 조직의 혈관 구조에 대한 가시성을 향상시키는 진단 영상 기법입니다. 이 기술은 장기나 병변내 혈관 패턴을 강조하여 진단의 정확도를 높이고, 기존 초음파보다 선명한 영상을 제공하는 경우가 많습니다.

주요 시장 성장 촉진요인

세계에서 증가하는 만성질환의 부담은 조영제 초음파 검사의 중요한 시장 성장 촉진요인입니다. 심혈관 질환, 암, 간질환 등의 질환은 조기 발견, 병기 결정, 치료 경과 관찰을 위해 정확하고 빈번한 진단 영상 검사가 필요합니다.

주요 시장 과제

세계에서 숙련된 초음파 검사 기술자의 부족은 조영제 초음파 검사 시장의 성장에 큰 도전이 되고 있습니다. CEUS 검사의 첨단 특성상 정확한 조작, 영상 획득 및 해석을 위해서는 전문적인 지식과 기술이 필요합니다.

주요 시장 동향

AI의 통합은 영상 분석 및 진단 능력을 향상시킴으로써 조영제 초음파 검사를 크게 향상시키고 있습니다. 인공지능 알고리즘은 세분화과 이상 징후를 자동화하고 워크플로우를 최적화하여 정확도와 효율성을 향상시키고 인적 오류를 줄일 수 있습니다.

목차

제1장 개요

제2장 조사 방법

제3장 개요

제4장 고객의 소리

제5장 세계의 조영제 강화 초음파 시장 전망

• 시장 규모·예측
  • 금액별
• 시장 점유율·예측
  • 제품별(장비, 조영제)
  • 유형별(비표적형, 표적형)
  • 최종사용자별(병원, 진료소, 외래 진단 센터)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 조영제 강화 초음파 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 조영제 강화 초음파 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 조영제 강화 초음파 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 조영제 강화 초음파 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 조영제 강화 초음파 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 촉진요인
• 과제

제12장 시장 동향과 발전

• 합병·인수
• 제품 출시
• 최근 동향

제13장 세계의 조영제 강화 초음파 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• Lantheus Holdings, Inc.
• General Electric Company
• Siemens Healthineers Company
• nanoPET Pharma GmbH
• ESAOTE SPA
• GE HealthCare Technologies, Inc.
• Koninklijke Philips N.V.
• Leriva SA

제16장 전략적 제안

제17장 조사회사 소개·면책사항

영문목차

The Global Contrast Enhanced Ultrasound Market, valued at USD 2.27 Billion in 2024, is projected to experience a CAGR of 4.65% to reach USD 2.98 Billion by 2030. Contrast-enhanced ultrasound (CEUS) is a diagnostic imaging modality that utilizes intravenously administered, gas-filled microbubbles to enhance the visualization of blood flow and tissue vascularization during standard medical sonography. This technique improves diagnostic precision by accentuating vascular patterns in organs and lesions, often providing clearer images than conventional ultrasound.

Key Market Drivers

The rising global burden of chronic diseases is a significant market driver for Contrast Enhanced Ultrasound. Conditions like cardiovascular disease, cancer, and hepatic disorders require accurate and frequent diagnostic imaging for early detection, staging, and monitoring treatment. CEUS provides a non-invasive, radiation-free method to precisely assess tissue perfusion and vascularity, which is crucial for characterizing lesions and evaluating organ function. This capability assists clinicians in making timely patient management decisions.

Key Market Challenges

The global scarcity of skilled sonographers poses a significant challenge to the growth of the Contrast Enhanced Ultrasound market. The sophisticated nature of CEUS procedures requires specialized expertise for accurate operation, image acquisition, and interpretation. Without an adequate pool of trained professionals, healthcare facilities face limitations in adopting and fully utilizing this advanced imaging modality, regardless of its diagnostic benefits.

Key Market Trends

AI integration is significantly enhancing contrast-enhanced ultrasound by improving image analysis and diagnostic capabilities. Artificial intelligence algorithms automate segmentation, anomaly detection, and optimize workflow, thereby improving accuracy and efficiency and potentially reducing human error. This technological advance enables faster interpretation of complex images and supports early disease detection, leading to improved patient outcomes. According to Medical Device Network, in July 2023, UltraSight received FDA approval for its AI-based cardiac ultrasound guidance technology, enabling medical professionals without prior sonography experience to capture diagnostic-quality images at the point of care.

Key Market Players

• Lantheus Holdings, Inc.
• General Electric Company
• Siemens Healthineers Company
• nanoPET Pharma GmbH
• ESAOTE SPA
• GE HealthCare Technologies, Inc.
• Koninklijke Philips N.V.
• Leriva SA

Report Scope:

In this report, the Global Contrast Enhanced Ultrasound Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Contrast Enhanced Ultrasound Market, By Product:

• Equipment
• Contrast Agents

Contrast Enhanced Ultrasound Market, By Type:

• Non-targeted
• Targeted

Contrast Enhanced Ultrasound Market, By End use:

• Hospitals
• Clinics
• Ambulatory Diagnostic Centers

Contrast Enhanced Ultrasound Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Contrast Enhanced Ultrasound Market.

Available Customizations:

Global Contrast Enhanced Ultrasound Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Contrast Enhanced Ultrasound Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Equipment, Contrast Agents)
  • 5.2.2. By Type (Non-targeted, Targeted)
  • 5.2.3. By End use (Hospitals, Clinics, Ambulatory Diagnostic Centers)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Contrast Enhanced Ultrasound Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Type
  • 6.2.3. By End use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Contrast Enhanced Ultrasound Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By End use
  • 6.3.2. Canada Contrast Enhanced Ultrasound Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By End use
  • 6.3.3. Mexico Contrast Enhanced Ultrasound Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By End use

7. Europe Contrast Enhanced Ultrasound Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Type
  • 7.2.3. By End use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Contrast Enhanced Ultrasound Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By End use
  • 7.3.2. France Contrast Enhanced Ultrasound Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By End use
  • 7.3.3. United Kingdom Contrast Enhanced Ultrasound Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By End use
  • 7.3.4. Italy Contrast Enhanced Ultrasound Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By End use
  • 7.3.5. Spain Contrast Enhanced Ultrasound Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By End use

8. Asia Pacific Contrast Enhanced Ultrasound Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Type
  • 8.2.3. By End use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Contrast Enhanced Ultrasound Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By End use
  • 8.3.2. India Contrast Enhanced Ultrasound Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By End use
  • 8.3.3. Japan Contrast Enhanced Ultrasound Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By End use
  • 8.3.4. South Korea Contrast Enhanced Ultrasound Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By End use
  • 8.3.5. Australia Contrast Enhanced Ultrasound Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By End use

9. Middle East & Africa Contrast Enhanced Ultrasound Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Type
  • 9.2.3. By End use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Contrast Enhanced Ultrasound Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By End use
  • 9.3.2. UAE Contrast Enhanced Ultrasound Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By End use
  • 9.3.3. South Africa Contrast Enhanced Ultrasound Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By End use

10. South America Contrast Enhanced Ultrasound Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Type
  • 10.2.3. By End use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Contrast Enhanced Ultrasound Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By End use
  • 10.3.2. Colombia Contrast Enhanced Ultrasound Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By End use
  • 10.3.3. Argentina Contrast Enhanced Ultrasound Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By End use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Contrast Enhanced Ultrasound Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Lantheus Holdings, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. General Electric Company
• 15.3. Siemens Healthineers Company
• 15.4. nanoPET Pharma GmbH
• 15.5. ESAOTE SPA
• 15.6. GE HealthCare Technologies, Inc.
• 15.7. Koninklijke Philips N.V.
• 15.8. Leriva SA

16. Strategic Recommendations

17. About Us & Disclaimer